Regional cerebral blood flow in Down's syndrome

Area of Science:

• Neurology
• Neuroscience
• Medical Research

Background:

• Down's syndrome and Alzheimer's disease are distinct neurological conditions.
• Cerebral blood flow (CBF) is a critical indicator of brain health.
• Previous research suggests potential links between Down's syndrome and an increased risk of Alzheimer's-like pathology.

Purpose of the Study:

• To investigate and compare regional cerebral blood flow (rCBF) in individuals with Down's syndrome and Alzheimer's disease.
• To identify similarities or differences in cerebral hemodynamics between the two conditions.

Main Methods:

• Utilized the xenon 133 inhalation technique to measure regional cerebral blood flow.
• Included 14 patients with Down's syndrome, 46 patients with Alzheimer's disease, and 114 age-matched healthy controls.
• Analyzed rCBF across frontal, temporal, parietal, and occipital regions in both cerebral hemispheres.

Main Results:

• 13 out of 14 patients with Down's syndrome exhibited a mean reduction of 16.8% +/- 2.5% in rCBF compared to age-matched controls.
• The pattern and magnitude of rCBF reduction in Down's syndrome patients were comparable to those observed in Alzheimer's disease patients.
• No significant differences in rCBF reduction were found across different brain regions in Down's syndrome patients.

Conclusions:

• Regional cerebral blood flow is significantly reduced in individuals with Down's syndrome.
• The observed pattern of reduced cerebral blood flow in Down's syndrome mirrors that seen in Alzheimer's disease.
• These findings suggest a shared pathophysiological mechanism or vulnerability in cerebral circulation between Down's syndrome and Alzheimer's disease.